Implantation Failure After IVF: Causes, Tests to Request, and How to Improve Chances

Written by the Fertility Team at Mannat Fertility | Medically reviewed by Dr. Trina Karmakar— Mannat Fertility, Bangalore

Medical disclaimer: This article is for general information only and is not a substitute for individual medical advice, diagnosis, or treatment. Always discuss your specific case, test results, and treatment options with your fertility specialist.

Key Takeaways

• A single failed embryo transfer is common and doesn’t automatically mean something is wrong — most specialists only start a deeper workup after two or three failed transfers with good-quality embryos.
• The leading cause of implantation failure is the embryo itself, usually a chromosomal abnormality, not the uterus.
• Some popular tests — including thrombophilia panels and most immune/NK-cell testing — are not recommended as routine by major bodies like ASRM and ESHRE, because the evidence linking them to implantation failure is weak.
• Useful, evidence-supported investigations usually focus on the uterine cavity, the endometrium, embryo genetics, and basic hormonal and semen parameters.
• Most couples who experience implantation failure do go on to have a successful pregnancy once the cause is identified and addressed.

What Counts as “Implantation Failure” After IVF?

Implantation failure simply means the embryo doesn’t attach and grow in the uterine lining after a transfer — the pregnancy test stays negative, or an initial rise in hCG doesn’t progress. It’s one of the most common reasons embryo transfers don’t lead to pregnancy, with implantation problems affecting around 10% of couples going through IVF.

A single failed transfer, especially in a first or second cycle, is not unusual and doesn’t necessarily point to an underlying problem — chromosomal issues in the embryo account for a large share of these early losses, and that risk rises with maternal age. The term recurrent implantation failure (RIF) is reserved for a more specific, repeated pattern. There’s no single agreed definition in the field, but specialists generally use it to describe two or three failed transfers of good-quality embryos in a uterus that looks structurally normal on imaging, in a woman who would otherwise be expected to conceive.

If you’ve had one disappointing cycle, it’s worth reading about the common reasons IVF cycles don’t result in pregnancy before assuming a deeper investigation is needed. If you’ve now had more than one, this is usually the point where your specialist will suggest a structured workup.

What Has to Go Right for Implantation to Happen

Implantation is a two-way conversation between the embryo and the endometrium (the uterine lining). For it to succeed, three things broadly need to line up:

1. A genetically and developmentally normal embryo capable of forming a blastocyst.
2. A receptive endometrium — the right thickness, blood supply, and hormonal preparation, timed to a narrow “window of implantation.”
3. No physical or inflammatory barrier in the uterine cavity, such as a polyp, scar tissue, or chronic low-grade infection.

When implantation repeatedly fails, the cause usually sits in one (or more) of these three areas.

Causes of Implantation Failure After IVF

1. Embryo-related factors

The most frequent reason an embryo doesn’t implant is a chromosomal abnormality (aneuploidy) that makes it non-viable, regardless of how good it looks under the microscope. This is one reason age matters so much in IVF outcomes — egg quality, and therefore embryo chromosomal normality, declines over time. Embryo fragmentation, slow development to the blastocyst stage, and poor sperm contribution (including high sperm DNA fragmentation) can also play a role. You can read more about how sperm DNA quality is assessed and improved if male-factor issues are suspected.

2. Uterine and endometrial factors

Structural issues inside the uterus are one of the more “fixable” causes of implantation failure:

• Thin or poorly developed endometrium — a lining that doesn’t thicken adequately in response to hormonal preparation. Learn more about evaluating and managing thin endometrium.
• Polyps, fibroids, or intrauterine adhesions (scar tissue) distorting the cavity.
• Chronic endometritis — a low-grade, often symptomless inflammation of the endometrial lining, increasingly recognized as a contributor to RIF.
• Hydrosalpinx — fluid in a damaged fallopian tube that can leak back into the uterus and disrupt the embryo.

3. Endometrial receptivity and timing

Even a structurally normal uterus has to be receptive at exactly the right moment — the “window of implantation.” In some women, this window is shifted earlier or later than the standard protocol assumes, so an embryo transferred on a “textbook” day arrives when the lining isn’t truly ready. This is the rationale behind receptivity testing, discussed below.

4. Hormonal and metabolic factors

Inadequate progesterone exposure, untreated thyroid dysfunction, and poorly controlled blood sugar can all interfere with how the endometrium prepares for an embryo.

5. Immunological and clotting (thrombophilia) factors

This is an area where the conversation in fertility clinics doesn’t always match the actual evidence. Uterine immune cell activity and clotting tendencies have been studied as possible causes of implantation failure, but large reviews from ESHRE and the American Society for Reproductive Medicine have found the evidence too weak to support routine testing or treatment for most patients — more on this in the next section.

6. Lifestyle and modifiable factors

Smoking (in either partner), elevated BMI, and high stress levels are recognized risk factors for recurrent implantation failure, alongside the biological causes above. These don’t replace a medical workup, but they’re worth addressing alongside it.

Tests to Request: What Actually Helps (And What Doesn’t)

This is the part where it pays to be a discerning patient. Not every test that sounds reasonable is actually supported by evidence — and unnecessary testing can mean unnecessary cost, delay, and worry. Based on current ESHRE good practice recommendations and ASRM guidance, here’s how the main investigations break down.

Tests with reasonable evidence behind them

• 3D ultrasound or hysteroscopy of the uterine cavity, to look for polyps, fibroids, adhesions, or a congenital uterine anomaly. If something is found, it’s often correctable — see our pages on hysteroscopic evaluation and surgery, polyp removal, and removal of intrauterine adhesions.
• Assessment for chronic endometritis, usually via endometrial biopsy with specific staining or culture. If confirmed, it’s typically treated with a course of antibiotics.
• Karyotyping of both partners, to rule out a balanced chromosomal rearrangement that could be affecting embryo viability.
• Thyroid function and progesterone levels, checked through standard blood investigations.
• Preimplantation genetic testing for aneuploidy (PGT-A) on embryos, particularly relevant after repeated failures, since it directly screens for the most common cause of implantation failure. Read more about preimplantation genetic screening.
• Semen analysis and sperm DNA fragmentation testing, especially if this hasn’t been done recently or thoroughly. See our male fertility assessment services.
• Endometrial receptivity testing (such as the ERA test) can be considered in specific RIF cases, though current guidelines are clear that the evidence doesn’t yet support its routine use for everyone — it assesses only one piece of a much larger picture. You can read about how this test works on our endometrial receptivity array page.

Tests that are often offered but aren’t routinely recommended

• Thrombophilia panels (Factor V Leiden, MTHFR, Protein C/S, etc.) — major societies do not currently recommend routine testing for implantation failure or recurrent loss, since multiple studies have found no clear difference in clotting disorder rates between affected and unaffected women.
• Broad immune panels and NK-cell testing — current guidance states the evidence is too limited and inconsistent to recommend these as standard, and treatments based on them (like IVIG or intralipids) aren’t supported outside of research settings.
• Antiphospholipid antibody testing is the one exception worth discussing with your doctor if you also have a personal or family history of blood clots or recurrent pregnancy loss, since antiphospholipid syndrome itself is a recognized, treatable condition.

If a clinic recommends an extensive (and expensive) panel of immune or clotting tests without a specific clinical reason, it’s entirely reasonable to ask what evidence supports that particular test for your situation.

How to Improve Your Chances Going Forward

Once a cause (or combination of causes) is identified, the next steps are usually targeted rather than generic:

• If the embryo is the likely issue: PGT-A on future embryos, optimizing the stimulation protocol, or considering donor eggs in select cases of repeated aneuploidy at advanced maternal age.
• If the uterine cavity is the issue: surgical correction (hysteroscopic removal of polyps/adhesions, or fibroid removal) before the next transfer.
• If the endometrium is thin or underdeveloped: extended estrogen priming, and in select cases, adjunct treatments such as sub-endometrial PRP, used alongside — not instead of — standard protocols.
• If chronic endometritis is confirmed: a targeted course of antibiotics before the next attempt.
• If male-factor contribution is suspected: addressing low sperm count or motility or high DNA fragmentation through lifestyle changes, medical treatment, or lab techniques like sperm selection.
• If timing may be off: your specialist may discuss receptivity testing as one input among several, not as a stand-alone fix.
• Across the board: addressing modifiable factors like smoking, weight, and stress management can meaningfully support the rest of the treatment plan, even though they’re rarely the sole cause.

It’s also worth saying plainly: a thorough workup after repeated implantation failure changes the conversation from “trying again and hoping” to “trying again with a specific plan.” Most couples with identified, treatable causes do go on to achieve a pregnancy — it just often takes one more step than the first cycle suggested.

When to Ask for a Deeper Workup

You don’t need to wait for a fixed number of failures before raising concerns. It’s reasonable to ask your specialist for a structured review if:

• You’ve had two or more transfers of good-quality (or genetically tested) embryos without implantation.
• A scan has ever suggested a polyp, fibroid, or irregular uterine cavity that wasn’t fully investigated.
• You have a personal or family history of blood clots, autoimmune disease, or recurrent miscarriage.
• You haven’t had a recent, thorough semen analysis if male partner factors haven’t been reassessed.
• You simply feel like the next cycle is being repeated without any change in plan.

A good fertility team should be able to explain, in plain language, what they think went wrong last time and what — specifically — is different this time.

Final Thoughts

Implantation failure after IVF is distressing, but it’s rarely unexplainable once it’s properly investigated. The most useful path forward isn’t more testing for its own sake — it’s the right, targeted tests, interpreted by a specialist who can tell you honestly which findings are likely to change your treatment plan and which aren’t.

If you’ve experienced more than one failed transfer, our team at Mannat Fertility can walk you through a structured evaluation and a personalized next-cycle plan. You can book a consultation with our specialists or learn more about our fertility specialists in Bangalore.